Detalhe da pesquisa
1.
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
BMC Cancer
; 19(1): 1102, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727024
2.
Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.
JCO Precis Oncol
; 6: e2200133, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446040
3.
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results.
J Bone Oncol
; 35: 100442, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35800293
4.
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clin Transl Radiat Oncol
; 25: 61-66, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072895
5.
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).
J Clin Oncol
; 31(21): 2685-91, 2013 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23796998